로딩 중…
지수 로딩 중…
크레오에스지
040350· KOSDAQ· Information Technology· Software & Services
₩9,010+7.13%
2026-06-19
Price Chart
크레오에스지+30.11%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 175.88B KRW |
| Revenue | 11.48B KRW |
| Net Income | -7.44B KRW |
| Total Assets | 88.62B KRW |
| Net Assets | 46.38B KRW |
| Employees | 47 |
| Value | |
| P/B | 3.79x |
| P/S | 15.33x |
| FCF Yield | -1.63% |
| Profitability | |
| ROE | -16.03% |
| ROA | -8.39% |
| Op. Margin | -45.44% |
| Revenue Growth | 30.49% |
| Financial Health | |
| Debt Ratio | 191.06% |
| Total Debt | 53.94B KRW |
| FCF | -2.87B KRW |
| Cash | 463.7M KRW |
| Current Ratio | 0.79x |
| Performance | |
| 1Y Return | 30.11% |
| 1M Return | 157.43% |
| From 52W High | -29.61% |
| 1Y MDD | -63.73% |
| Trading | |
| Volume | 165,333 shares |
| Foreign Own. | 0.92% |
| Per Share | |
| EPS | -382 KRW |
| BPS | 2,388 KRW |
Company Info
CreoSG, established in 1997 and KOSDAQ-listed in 2002, strengthened its solutions business through a 2005 merger and expanded real estate operations in 2024. The company has diversified its portfolio to include solutions for financial institutions, bio-business for infectious disease vaccine development, and real estate operation and rental management. Leveraging its experience in financial system implementation, it is expanding into manufacturing and service sectors. CreoSG also pursues vaccine research and development utilizing system migration and a universal new drug development platform. It is headquartered in Gangnam-gu, Seoul Metropolitan City.